pancreatic pseudocystsspecialty hospitalswalled-off necrosisWONPCsPFCsLAMSsplastic stents
…uid collections (PFCs), including walled-off necrosis (WON) and pancreatic pseudocysts (PCs).Objective To evaluate the nationwide impact of implementi…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 386 of 2459COVID-19COPDchronic obstructive pulmonary diseaseinhaled therapy prescriptionsLong covid
…ing occurrence after subsequent infections.Conclusion Recurrent COVID-19 infections in patients with COPD were linked to progressively h…
PED-PZQSchistosoma mansoni infectionS. mansonischistosomiasisPZQ
…will enrol 163 children aged 3 months to 3 years, all receiving PED-PZQ. Both trials are open label. Eligible participants shall meet a…
D2T RAmethotrexaterheumatoid arthritisfibromyalgiab/tsDMARD switching
… to 9.7).Conclusions A subset of patients with low-inflammatory D2T RA may benefit from b/tsDMARD switching, indicating that low-infla…
simvastatinchronic pancreatitispancreatitisCPRAPWu et alGuilabert et al.
…d trial by Guilabert et al.1 The authors tested the efficacy of simvastatin or placebo in patients with recurrent acute pancreatitis (RAP) …
azithromycinchronic lung disease of prematurityAzithromycin-resistant
…ably prevalent in the placebo group, with minimal increase with azithromycin treatment, suggesting that, regardless of the additional use of…
rHGHKnOAHealth Canada Clinical TrialsSunnybrook Research InstituteSaizenphysical therapyKnee OsteoarthritisCCTSlower limb strengthening programme
…n combined with exercise treatment in adult populations. Hence, rHGH combined with physical therapy may provide meaningful benefits …
dual antiplatelet therapyost traumatic stress disorderMedicaidDAPTpost traumatic stress disorder
…r to predict bleeding risk during coronary stenting followed by dual antiplatelet therapy, based on conditions described in box 2. Top panel: simulated P…
Asthmaairway inflammation
…inflammatory characteristics, adjusting for age and sex.Results Asthma inflammatory phenotypes and microbiology differed between count…
rheumatic heart diseaseacute rheumatic feverpharyngitisimpetigoacute post-streptococcal glomerulonephritisThe Kids Research Institute AustraliaUniversity of Western AustraliaStrep A
…s and immune-mediated conditions such as acute rheumatic fever, rheumatic heart disease and acute post-streptococcal glomerulonephritis. Contemporary d…
Disease Activity Score 28rheumatoid arthritiscertolizumab pegolRANCT00717236CZP
…el CZP (minimum 16 weeks). Outcomes reported to week 36 include Disease Activity Score 28 C-reactive protein (DAS28-CRP) and Clinical Disease Activity In…
RituximabPrednisoloneCyclophosphamideHydroxydaunorubicinOncovinNSTINecrotising soft tissue infectionNFR-CHOPnecrotising fasciitis
… case involves a patient who developed NF 12 days after R-CHOP (Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone) …